物质信息
ID:1849465
名称和标识
IUPAC标准名
4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione
IUPAC传统名
oxyphenbutazone
别名
oxyphenbutazone1-(p-Hydroxyphenyl)-2-phenyl-4-butyl-3,5-pyrazolidinedione1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-butylpyrazolidine1-Phenyl-2-(p-hydroxyphenyl)-3,5-dioxo-4-n-butylpyrazolidine3,5-Dioxo-1-phenyl-2-(p-hydroxyphenyl)-4-N-butylpyrazolidene4-Butyl-1-(4-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione4-Butyl-1-(p-hydroxyphenyl)-2-phenyl-3,5-pyrazolidinedione4-Butyl-2-(4-hydroxyphenyl)-1-phenyl-3,5-dioxopyrazolidine4-Butyl-2-(p-hydroxyphenyl)-1-phenyl-3,5-pyrazolidinedioneHydroxyphenylbutazonOxi-fenibutolOxifenylbutazonOxiphenbutazonumOxyphenylbutazonep-Hydroxyphenylbutazonep-Oxyphenylbutazone
国际非专利药品(INN)
oxifenbutazonaoxyphenbutazoneoxyphenbutazonum
数据登录号
PubChem CID
CAS号
DrugBank ID
KEGG ID
LINCS数据库
PubMed文献链接
Reaxys Registry
ACToR数据库
BKMS React数据库
BRENDA Ligand数据库
CHEMBL
CompTox数据库
SureChEMBL数据库
维基百科标题
Drug Central Database
BindingDB数据库
KEGG DRUG Database
CHEBI ID
PubChem SID
化合物性质
暂无数据
点击上传数据
描述信息
A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.
分子图谱
暂无数据
点击上传数据
参考文献
暂无数据
点击上传数据